Skip to content
Clinical Trials – home

COCARBOXYLASE TETRAHYDRATE: A Comprehensive Guide for Patients

1 / 2
trials open to patients / all trials
2+
Countries

In short

Cocarboxylase Tetrahydrate, a component found in vitamin supplements, is currently being studied in clinical trials for its potential role in treating cardiogenic shock. This article explores the ongoing research into this compound's effectiveness when used alongside other treatments for patients with severe heart conditions. We'll examine the objectives, methods, and potential outcomes of these trials to better understand how Cocarboxylase Tetrahydrate might contribute to improving patient care in critical cardiac situations.

At a glance

Drug Studied
Cocarboxylase Tetrahydrate (as part of Cernevit vitamin supplement)
Medical Condition
Cardiogenic Shock
Primary Objectives
Assess efficacy in improving cardiac output, facilitating ECMO weaning, and reducing mortality
Study Design
Randomized, controlled trials comparing treatment with conventional strategies
Key Endpoints
Changes in cardiac function, mortality rates, ECMO weaning success, organ function preservation
Patient Eligibility
Adults with cardiogenic shock, meeting specific inclusion criteria
Potential Impact
Improved treatment strategies for cardiogenic shock, potentially reducing mortality and improving patient outcomes

What is Cocarboxylase Tetrahydrate?

Cocarboxylase Tetrahydrate is a medical compound that is part of a group of substances known as vitamins. It is one of the active ingredients in a medication called Cernevit, which is a multivitamin preparation used in various medical settings. Cocarboxylase is another name for thiamine pyrophosphate, which is the active form of vitamin B1 (thiamine) in the body.

Medical Uses

Cocarboxylase Tetrahydrate, as part of the Cernevit formulation, is primarily used in the following situations:

  • To provide vitamin supplementation for patients who cannot eat normally
  • In patients receiving parenteral nutrition (nutrition given through a vein)
  • To prevent or treat vitamin deficiencies in critically ill patients

While the specific role of Cocarboxylase Tetrahydrate is not explicitly stated in the provided clinical trial information, its presence in Cernevit suggests it plays a crucial role in maintaining proper vitamin B1 levels in the body.

Administration

Cernevit, which contains Cocarboxylase Tetrahydrate, is typically administered as follows:

  • It comes as a powder that is mixed to create a solution for injection or infusion
  • The medication is usually given intravenously (directly into a vein)
  • The dosage and frequency of administration are determined by healthcare professionals based on the patient's individual needs

Ongoing Research

While the clinical trials mentioned do not specifically focus on Cocarboxylase Tetrahydrate, they provide insight into the contexts where this compound might be used:

  • The trials are investigating the use of levosimendan, another cardiac medication, in patients with cardiogenic shock (a condition where the heart suddenly can't pump enough blood to meet the body's needs)
  • Patients in these trials may receive various supportive treatments, including vitamin supplementation, which could potentially involve Cernevit and its component Cocarboxylase Tetrahydrate

Potential Benefits

While not directly studied in the provided trials, Cocarboxylase Tetrahydrate, as part of vitamin B1, may offer the following benefits:

  • Support for energy metabolism in the body
  • Maintenance of proper nervous system function
  • Potential support for heart function, which could be particularly relevant in patients with cardiac conditions

Considerations and Precautions

When receiving treatment that includes Cocarboxylase Tetrahydrate (as part of Cernevit), patients should be aware of the following:

  • This medication is typically administered by healthcare professionals in a controlled setting
  • It's important to inform your doctor about any allergies or sensitivities you may have to vitamins or other medications
  • While vitamin supplementation is generally safe, it should be done under medical supervision, especially in critically ill patients

As always, it's crucial to discuss any questions or concerns about your treatment with your healthcare provider. They can provide personalized information based on your specific medical condition and needs.

Questions people often ask

Conditions where Cocarboxylase Tetrahydrate is being studied

Each condition opens its own overview and trial list

Trials with Cocarboxylase Tetrahydrate

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.